Prof Douglas Kell Research Sandpit Meeting

A Research Sandpit Meeting was held at the Manchester Institute of Biotechnology on 20 February between representatives of AstraZeneca and the University of Manchester. 

An overview of AstraZeneca’s cardiovascular safety strategy was presented in the context of the drug discovery process and a brainstorming session followed to discuss potential areas of collaboration.

Douglas’ most recent publications are at

▲ Up to the top